Business Description
Integrum AB
ISIN : SE0009807266
Share Class Description:
FRA:6Y1: BTotal Employee Number:
34Compare
Compare
Traded in other countries / regions
INTEG B.Sweden6Y1.Germany IPO Date
2020-12-23Description
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.01 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.08 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 3.16 | |||||
Beneish M-Score | -2.42 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.8 | |||||
3-Year EBITDA Growth Rate | -17 | |||||
3-Year EPS without NRI Growth Rate | -31.6 | |||||
3-Year FCF Growth Rate | -8 | |||||
3-Year Book Growth Rate | -5.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.03 | |||||
9-Day RSI | 44.95 | |||||
14-Day RSI | 48.26 | |||||
3-1 Month Momentum % | -7.37 | |||||
6-1 Month Momentum % | -25.03 | |||||
12-1 Month Momentum % | -57.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.77 | |||||
Quick Ratio | 1.8 | |||||
Cash Ratio | 0.63 | |||||
Days Inventory | 392.57 | |||||
Days Sales Outstanding | 108.13 | |||||
Days Payable | 91.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | -17.1 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.19 | |||||
Operating Margin % | -56.33 | |||||
Net Margin % | -50.71 | |||||
EBITDA Margin % | -45.07 | |||||
FCF Margin % | -62.22 | |||||
OCF Margin % | -47.42 | |||||
ROE % | -27.03 | |||||
ROA % | -23.51 | |||||
ROIC % | -26.87 | |||||
3-Year ROIIC % | -42.91 | |||||
ROC (Joel Greenblatt) % | -125.3 | |||||
ROCE % | -30.55 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.05 | |||||
PB Ratio | 1.23 | |||||
Price-to-Tangible-Book | 2.02 | |||||
EV-to-EBIT | -3.7 | |||||
EV-to-EBITDA | -4.77 | |||||
EV-to-Revenue | 2.15 | |||||
EV-to-FCF | -3.46 | |||||
Price-to-GF-Value | 0.45 | |||||
| Price-to-Net-Current-Asset-Value | 4.05 | |||||
Earnings Yield (Greenblatt) % | -27.03 | |||||
FCF Yield % | -26.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Integrum AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 8.362 | ||
| EPS (TTM) (€) | -0.177 | ||
| Beta | 1.4978 | ||
| 3-Year Sharpe Ratio | 0.22 | ||
| 3-Year Sortino Ratio | 0.39 | ||
| Volatility % | 145.56 | ||
| 14-Day RSI | 48.26 | ||
| 14-Day ATR (€) | 0.012452 | ||
| 20-Day SMA (€) | 0.6914 | ||
| 12-1 Month Momentum % | -57.44 | ||
| 52-Week Range (€) | 0.588 - 3.9008 | ||
| Shares Outstanding (Mil) | 26.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Integrum AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Integrum AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-12-03 | In 136 days | ||
| Second quarter earnings results for 2027 | 2026-12-03 | In 136 days | ||
| Second quarter earnings conference call for 2027 | 2026-12-01 10:00 | In 135 days | ||
| Second quarter earnings results for 2027 | 2026-12-01 | In 134 days | ||
| General meeting for 2026 | 2026-10-29 15:00 | In 102 days | ||
| First quarter earnings conference call for 2027 | 2026-09-03 | In 45 days | ||
| First quarter earnings results for 2027 | 2026-09-03 | In 45 days | ||
| First quarter earnings conference call for 2027 | 2026-09-01 10:00 | In 44 days | ||
| First quarter earnings results for 2027 | 2026-09-01 | In 43 days | ||
| Annual report for 2026 | 2026-08-20 | In 31 days |
Show
Entries
Integrum AB Frequently Asked Questions
What is Integrum AB(FRA:6Y1)'s stock price today?
The current price of FRA:6Y1 is €0.69. The 52 week high of FRA:6Y1 is €3.90 and 52 week low is €0.59.
When is next earnings date of Integrum AB(FRA:6Y1)?
The next earnings date of Integrum AB(FRA:6Y1) is 2026-09-01 Est..
Does Integrum AB(FRA:6Y1) pay dividends? If so, how much?
Integrum AB(FRA:6Y1) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Integrum Unveils Global Marketing Strategy at AOPA National Assembly | 2025-09-04 |
Articles on Integrum AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers